Various factors may have contributed to these mixed results, including participant heterogeneity, compliance issues, and the aggressive placebo response often seen in obesity trials where lifestyle modification is encouraged
It is especially appealing for individuals focused on improving body composition (reducing fat, preserving muscle) and in settings where lifestyle supports are in place
Preclinical studies using metabolic assays such as euglycemic clamp techniques indicate that AOD 9604 does not impair insulin-mediated glucose uptake in adipose or peripheral tissues
The rest is held in reserve, mostly bound to ferritin in your liver, spleen, bone marrow, and skeletal muscle
As a result, finding effective treatment options for FIP has been a critical goal for veterinarians and researchers